-
Public Policy and Parkinson’s Disease: Our 2025 Priorities for Federal and State Governments
January 21, 2025
… Prevention National Neurological Conditions Surveillance System. This data system can fuel research by collecting and analyzing … and reduce long-term costs for patients and health care systems. Last year, MJFF partnered with Pennsylvania …
-
The Sherer Report: April 2012
April 19, 2012
… progress toward new treatments that bypass the dopamine system altogether, as well as new formulations of dopamine … a treatment, droxidopa, which targets the noradrenaline system, another chemical that functions in the brain. … of PD based on the role of noradrenaline in the nervous system — which MJFF is helping researchers to explore. In …
-
LRRK2 Investigative Therapeutics Exchange (LITE)
… and clinical development. This includes access to model systems, assay platforms, medicinal chemistry expertise, and … biosamples and clinical data, now in progress across multiple global sites. Begin testing candidate biomarkers to …
-
Our Strategic Research Agenda
… By supporting platform trials — a clinical trial in which multiple treatments can be tested at once within one … research advances into better care. And policymakers build systems that support quality, meaningful and accessible …
-
Identification and Validation of the Modifiers of LRRK2-induced Toxicity
… in primary neuronal cultures and the LRRK2 Drosophila model system. Project Description : A budding yeast model of …
-
Generation and Characterization of iPS Neurons from PINK1- and Parkin-linked Parkinson's Disease
… human derived cell models to validate findings in other systems and to investigate novel disease mechanisms. This …